Sökning: WFRF:(Halayko Andrew J.) >
Brevinin-2R semi-se...
Brevinin-2R semi-selectively kills cancer cells by a distinct mechanism, which involves the lysosomal-mitochondrial death pathway
-
Ghavami, Saeid (författare)
-
Asoodeh, Ahmad (författare)
-
Klonisch, Thomas (författare)
-
visa fler...
-
Halayko, Andrew J. (författare)
-
Kadkhoda, Kamran (författare)
-
Kroczak, Tadeusz J. (författare)
-
Gibson, Spencer B. (författare)
-
Booy, Evan P. (författare)
-
Naderi-Manesh, Hossein (författare)
-
Los, Marek Jan (författare)
-
visa färre...
- Wiley-Blackwell 2008
- 2008
- Engelska.
-
Ingår i: Journal of Cellular and Molecular Medicine (Print). - 1582-1838. ; 12:3, 1005-1022
Abstract
Ämnesord
Stäng
- Brevinin-2R is a novel non-hemolytic defensin that was isolated from the skin of the frog Rana ridibunda . It exhibits preferential cytotoxicity towards malignant cells, including Jurkat (T-cell leukemia), BJAB (B-cell lymphoma), HT29/219, SW742 (colon carcinomas), L929 (fibrosarcoma), MCF-7 (breast adenocarcinoma), A549 (lung carcinoma), as compared to primary cells including peripheral blood mononuclear cells (PBMC), T cells and human lung fibroblasts. Jurkat and MCF-7 cells overexpressing Bcl2, and L929 and MCF-7 over-expressing a dominant-negative mutant of a pro-apoptotic BNIP3 (ΔTM-BNIP3) were largely resistant towards Brevinin-2R treatment. The decrease in mitochondrial membrane potential (ΔΨm), or total cellular ATP levels, and increased reactive oxygen species (ROS) production, but not caspase activation or the release of apoptosis-inducing factor (AIF) or endonuclease G (Endo G), were early indicators of Brevinin-2R-triggered death. Brevinin-2R interacts with both early and late endosomes. Lysosomal membrane permeabilization inhibitors and inhibitors of cathepsin-B and cathepsin-L prevented Brevinin-2R-induced cell death. Autophagosomes have been detected upon Brevinin-2R treatment. Our results show that Brevinin-2R activates the lysosomalmitochondrial death pathway, and involves autophagy-like cell death.
Ämnesord
- Medical and Health Sciences (hsv)
- Clinical Medicine (hsv)
- Cancer and Oncology (hsv)
- Medicin och hälsovetenskap (hsv)
- Klinisk medicin (hsv)
- Cancer och onkologi (hsv)
- Medical Biotechnology (hsv)
- Medical Biotechnology (with a focus on Cell Biology (including Stem Cell Biology), Molecular Biology, Microbiology, Biochemistry or Biopharmacy) (hsv)
- Medicinsk bioteknologi (hsv)
- Medicinsk bioteknologi (med inriktning mot cellbiologi (inklusive stamcellsbiologi), molekylärbiologi, mikrobiologi, biokemi eller biofarmaci) (hsv)
- Natural Sciences (hsv)
- Biological Sciences (hsv)
- Cell Biology (hsv)
- Naturvetenskap (hsv)
- Biologiska vetenskaper (hsv)
- Cellbiologi (hsv)
- Biochemistry and Molecular Biology (hsv)
- Biokemi och molekylärbiologi (hsv)
Nyckelord
- antibacterial peptide; defensin; Brevinin-2R; cell death; caspase activation; lysosomotrophic agent; late and early endosome; ROS; mitochondrial pathway; targetted cancer therapy
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Ghavami, Saeid
-
Asoodeh, Ahmad
-
Klonisch, Thomas
-
Halayko, Andrew ...
-
Kadkhoda, Kamran
-
Kroczak, Tadeusz ...
-
visa fler...
-
Gibson, Spencer ...
-
Booy, Evan P.
-
Naderi-Manesh, H ...
-
Los, Marek Jan
-
visa färre...
- Av lärosätet
-
Swepub_uni:_t